Literature DB >> 32188976

The Transcription Factor NR4A2 Plays an Essential Role in Driving Prolactin Expression in Female Pituitary Lactotropes.

Michael T Peel1, Yugong Ho1, Stephen A Liebhaber1,2.   

Abstract

Differentiation of the hormone-producing cells of the pituitary represents an informative model of cell fate determination. The generation and maintenance of 2 pituitary lineages, the growth hormone (GH)- producing somatotropes and the prolactin (PRL)- producing lactotropes, are dependent on the pituitary-specific transcription factor, POU1F1. While POU1F1 is expressed in both cell types, and plays a role in activation of both the Gh and Prl genes, expression of Gh and Prl is restricted to somatotropes and lactotropes, respectively. These observations imply the existence of additional factors that contribute to the somatotrope and lactotrope identities and their hormone expressions. Prior transcriptome analysis of primary somatotropes and lactotropes isolated from the mouse pituitary identified enrichment of a transcription factor, Nr4a2, in the lactotropes. Nr4a2 was shown in a cell culture model to bind the Prl promoter at a position adjacent to Pou1f1 and to synergize with Pou1f1 in driving Prl transcription. Here we demonstrate in vivo the role of Nr4a2 as an enhancer of Prl expression by conditional gene inactivation of the Nr4a2 gene in mouse lactotropes. We demonstrate that nuclear orphan receptor transcription factor (NR4A2) binding at the Prl promoter is dependent on actions of POU1F1; while POU1F1 is essential to loading polymerase (Pol) II on the Prl promoter, Nr4a2 plays a role in enhancing Pol II release into the Prl gene body. These studies establish an in vivo role of Nr4a2 in enhancing Prl expression in mouse lactotropes, explore its mechanism of action, and establish a system for further study of the lactotrope lineage in the pituitary. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Nr4a2; RNA-seq; lactotrope; pituitary; somatotrope

Mesh:

Substances:

Year:  2020        PMID: 32188976      PMCID: PMC7195901          DOI: 10.1210/endocr/bqaa046

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  26 in total

Review 1.  Molecular physiology of pituitary development: signaling and transcriptional networks.

Authors:  Xiaoyan Zhu; Anatoli S Gleiberman; Michael G Rosenfeld
Journal:  Physiol Rev       Date:  2007-07       Impact factor: 37.312

2.  A pituitary POU domain protein, Pit-1, activates both growth hormone and prolactin promoters transcriptionally.

Authors:  H J Mangalam; V R Albert; H A Ingraham; M Kapiloff; L Wilson; C Nelson; H Elsholtz; M G Rosenfeld
Journal:  Genes Dev       Date:  1989-07       Impact factor: 11.361

Review 3.  Role of Pit-1 in the gene expression of growth hormone, prolactin, and thyrotropin.

Authors:  L E Cohen; F E Wondisford; S Radovick
Journal:  Endocrinol Metab Clin North Am       Date:  1996-09       Impact factor: 4.741

4.  Classifications of anterior pituitary cell types with immunoenzyme histochemistry.

Authors:  P K Nakane
Journal:  J Histochem Cytochem       Date:  1970-01       Impact factor: 2.479

Review 5.  Born to run: control of transcription elongation by RNA polymerase II.

Authors:  Fei Xavier Chen; Edwin R Smith; Ali Shilatifard
Journal:  Nat Rev Mol Cell Biol       Date:  2018-07       Impact factor: 94.444

Review 6.  Pit-1 determines cell types during development of the anterior pituitary gland. A model for transcriptional regulation of cell phenotypes in mammalian organogenesis.

Authors:  B Andersen; M G Rosenfeld
Journal:  J Biol Chem       Date:  1994-11-25       Impact factor: 5.157

Review 7.  Functional consequences of bidirectional promoters.

Authors:  Wu Wei; Vicent Pelechano; Aino I Järvelin; Lars M Steinmetz
Journal:  Trends Genet       Date:  2011-05-24       Impact factor: 11.639

8.  Use of a prolactin-Cre/ROSA-YFP transgenic mouse provides no evidence for lactotroph transdifferentiation after weaning, or increase in lactotroph/somatotroph proportion in lactation.

Authors:  Emma Castrique; Marta Fernandez-Fuente; Paul Le Tissier; Andy Herman; Andy Levy
Journal:  J Endocrinol       Date:  2010-02-05       Impact factor: 4.286

9.  Cell-specific expression of the prolactin gene in transgenic mice is controlled by synergistic interactions between promoter and enhancer elements.

Authors:  E B Crenshaw; K Kalla; D M Simmons; L W Swanson; M G Rosenfeld
Journal:  Genes Dev       Date:  1989-07       Impact factor: 11.361

10.  Bidirectional promoters generate pervasive transcription in yeast.

Authors:  Zhenyu Xu; Wu Wei; Julien Gagneur; Fabiana Perocchi; Sandra Clauder-Münster; Jurgi Camblong; Elisa Guffanti; Françoise Stutz; Wolfgang Huber; Lars M Steinmetz
Journal:  Nature       Date:  2009-01-25       Impact factor: 49.962

View more
  2 in total

Review 1.  The role of NURR1 in metabolic abnormalities of Parkinson's disease.

Authors:  Murad Al-Nusaif; Yuting Yang; Song Li; Cheng Cheng; Weidong Le
Journal:  Mol Neurodegener       Date:  2022-06-27       Impact factor: 18.879

2.  Seasonal differences in the transcriptome profile of the Zhedong white goose (Anser cygnoides) pituitary gland.

Authors:  Wanqiu Zhao; Taoyan Yuan; Yan Fu; Dong Niu; Weihu Chen; Li Chen; Lizhi Lu
Journal:  Poult Sci       Date:  2020-11-03       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.